This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
10 - 12 June, 2025
Congress CenterBasel Switzerland

Joe de Rutte, PhD
Co-Founder and President at Partillion Bioscience
Speaker

Profile

Dr. Joe de Rutte is the Co-Founder and CEO of Partillion Bioscience, a venture-backed startup that is commercializing the Nanovial technology he pioneered during his PhD at UCLA. This technology utilizes hydrogel microparticles to enable researchers to perform microfluidic assays without the need for new, complex instruments. The impact of his work has been recognized by leaders in the field, earning him the top Innovation Award at SLAS 2020 and the New Product Award in 2022. Since its inception, Dr. de Rutte has led Partillion, successfully raising venture capital funding and launching its first commercial products. These developments address a growing need for functional analysis of cells, showcasing the significant contributions of Dr. de Rutte and his team to the scientific community.

Agenda Sessions

  • Advancing Antibody Discovery and Functional Screening with Nanovials and Flow Cytometry

    16:55